| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:NAA15-LPAR1 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: NAA15-LPAR1 | FusionPDB ID: 56943 | FusionGDB2.0 ID: 56943 | Hgene | Tgene | Gene symbol | NAA15 | LPAR1 | Gene ID | 80155 | 1902 |
| Gene name | N-alpha-acetyltransferase 15, NatA auxiliary subunit | lysophosphatidic acid receptor 1 | |
| Synonyms | Ga19|MRD50|NARG1|NAT1P|NATH|TBDN|TBDN100 | EDG2|GPR26|Gpcr26|LPA1|Mrec1.3|VZG1|edg-2|rec.1.3|vzg-1 | |
| Cytomap | 4q31.1 | 9q31.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | N-alpha-acetyltransferase 15, NatA auxiliary subunitN-terminal acetyltransferaseNMDA receptor regulated 1NMDA receptor-regulated protein 1gastric cancer antigen Ga19protein tubedown-1transcriptional coactivator tubedown-100tubedown-1 | lysophosphatidic acid receptor 1LPA receptor 1LPA-1endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2lysophosphatidic acid receptor Edg-2ventricular zone gene 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9BXJ9 | Q92633 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000296543, ENST00000398947, ENST00000480277, ENST00000515576, | ENST00000358883, ENST00000374430, ENST00000374431, ENST00000538760, ENST00000541779, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 18 X 10 X 7=1260 | 10 X 6 X 6=360 |
| # samples | 21 | 11 | |
| ** MAII score | log2(21/1260*10)=-2.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/360*10)=-1.71049338280502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: NAA15 [Title/Abstract] AND LPAR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | NAA15(140222985)-LPAR1(113638002), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | NAA15-LPAR1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NAA15-LPAR1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. NAA15-LPAR1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. NAA15-LPAR1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. NAA15-LPAR1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | NAA15 | GO:0006474 | N-terminal protein amino acid acetylation | 15496142 |
| Hgene | NAA15 | GO:0045893 | positive regulation of transcription, DNA-templated | 12145306 |
| Tgene | LPAR1 | GO:0007202 | activation of phospholipase C activity | 19306925 |
| Fusion gene breakpoints across NAA15 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across LPAR1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | GBM | TCGA-06-0129-01A | NAA15 | chr4 | 140222985 | - | LPAR1 | chr9 | 113638002 | - |
| ChimerDB4 | GBM | TCGA-06-0129-01A | NAA15 | chr4 | 140222985 | + | LPAR1 | chr9 | 113638002 | - |
| ChimerDB4 | GBM | TCGA-06-0129 | NAA15 | chr4 | 140222985 | + | LPAR1 | chr9 | 113638002 | - |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000296543 | NAA15 | chr4 | 140222985 | + | ENST00000541779 | LPAR1 | chr9 | 113638002 | - | 2836 | 377 | 277 | 678 | 133 |
| ENST00000296543 | NAA15 | chr4 | 140222985 | + | ENST00000538760 | LPAR1 | chr9 | 113638002 | - | 924 | 377 | 277 | 678 | 133 |
| ENST00000398947 | NAA15 | chr4 | 140222985 | + | ENST00000541779 | LPAR1 | chr9 | 113638002 | - | 2703 | 244 | 144 | 545 | 133 |
| ENST00000398947 | NAA15 | chr4 | 140222985 | + | ENST00000538760 | LPAR1 | chr9 | 113638002 | - | 791 | 244 | 144 | 545 | 133 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000296543 | ENST00000541779 | NAA15 | chr4 | 140222985 | + | LPAR1 | chr9 | 113638002 | - | 0.64831036 | 0.35168967 |
| ENST00000296543 | ENST00000538760 | NAA15 | chr4 | 140222985 | + | LPAR1 | chr9 | 113638002 | - | 0.37304795 | 0.626952 |
| ENST00000398947 | ENST00000541779 | NAA15 | chr4 | 140222985 | + | LPAR1 | chr9 | 113638002 | - | 0.48540062 | 0.5145994 |
| ENST00000398947 | ENST00000538760 | NAA15 | chr4 | 140222985 | + | LPAR1 | chr9 | 113638002 | - | 0.24640578 | 0.75359416 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >56943_56943_1_NAA15-LPAR1_NAA15_chr4_140222985_ENST00000296543_LPAR1_chr9_113638002_ENST00000538760_length(amino acids)=133AA_BP=33 MTEPGGGGSSGSSRNDAGREPPAQGECALQADLGAFIICWTPGLVLLLLDVCCPQCDVLAYEKFFLLLAEFNSAMNPIIYSYRDKEMSAT -------------------------------------------------------------- >56943_56943_2_NAA15-LPAR1_NAA15_chr4_140222985_ENST00000296543_LPAR1_chr9_113638002_ENST00000541779_length(amino acids)=133AA_BP=33 MTEPGGGGSSGSSRNDAGREPPAQGECALQADLGAFIICWTPGLVLLLLDVCCPQCDVLAYEKFFLLLAEFNSAMNPIIYSYRDKEMSAT -------------------------------------------------------------- >56943_56943_3_NAA15-LPAR1_NAA15_chr4_140222985_ENST00000398947_LPAR1_chr9_113638002_ENST00000538760_length(amino acids)=133AA_BP=33 MTEPGGGGSSGSSRNDAGREPPAQGECALQADLGAFIICWTPGLVLLLLDVCCPQCDVLAYEKFFLLLAEFNSAMNPIIYSYRDKEMSAT -------------------------------------------------------------- >56943_56943_4_NAA15-LPAR1_NAA15_chr4_140222985_ENST00000398947_LPAR1_chr9_113638002_ENST00000541779_length(amino acids)=133AA_BP=33 MTEPGGGGSSGSSRNDAGREPPAQGECALQADLGAFIICWTPGLVLLLLDVCCPQCDVLAYEKFFLLLAEFNSAMNPIIYSYRDKEMSAT -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr4:140222985/chr9:113638002) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NAA15 | LPAR1 |
| FUNCTION: Auxillary subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Required to control retinal neovascularization in adult ocular endothelial cells. In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter. {ECO:0000269|PubMed:11687548, ECO:0000269|PubMed:12145306, ECO:0000269|PubMed:15496142}. | FUNCTION: Receptor for lysophosphatidic acid (LPA) (PubMed:9070858, PubMed:19306925, PubMed:25025571, PubMed:26091040). Plays a role in the reorganization of the actin cytoskeleton, cell migration, differentiation and proliferation, and thereby contributes to the responses to tissue damage and infectious agents. Activates downstream signaling cascades via the G(i)/G(o), G(12)/G(13), and G(q) families of heteromeric G proteins. Signaling inhibits adenylyl cyclase activity and decreases cellular cAMP levels (PubMed:26091040). Signaling triggers an increase of cytoplasmic Ca(2+) levels (PubMed:19656035, PubMed:19733258, PubMed:26091040). Activates RALA; this leads to the activation of phospholipase C (PLC) and the formation of inositol 1,4,5-trisphosphate (PubMed:19306925). Signaling mediates activation of down-stream MAP kinases (By similarity). Contributes to the regulation of cell shape. Promotes Rho-dependent reorganization of the actin cytoskeleton in neuronal cells and neurite retraction (PubMed:26091040). Promotes the activation of Rho and the formation of actin stress fibers (PubMed:26091040). Promotes formation of lamellipodia at the leading edge of migrating cells via activation of RAC1 (By similarity). Through its function as lysophosphatidic acid receptor, plays a role in chemotaxis and cell migration, including responses to injury and wounding (PubMed:18066075, PubMed:19656035, PubMed:19733258). Plays a role in triggering inflammation in response to bacterial lipopolysaccharide (LPS) via its interaction with CD14. Promotes cell proliferation in response to lysophosphatidic acid. Required for normal skeleton development. May play a role in osteoblast differentiation. Required for normal brain development. Required for normal proliferation, survival and maturation of newly formed neurons in the adult dentate gyrus. Plays a role in pain perception and in the initiation of neuropathic pain (By similarity). {ECO:0000250|UniProtKB:P61793, ECO:0000269|PubMed:18066075, ECO:0000269|PubMed:19306925, ECO:0000269|PubMed:19656035, ECO:0000269|PubMed:19733258, ECO:0000269|PubMed:25025571, ECO:0000269|PubMed:26091040, ECO:0000269|PubMed:9070858, ECO:0000305|PubMed:11093753, ECO:0000305|PubMed:9069262}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 281_294 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 316_364 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 281_294 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 316_364 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 281_294 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 316_364 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 295_315 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D7 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 295_315 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D7 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 295_315 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D7 |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 629_632 | 18.0 | 867.0 | Compositional bias | Note=Poly-Asp |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 612_629 | 18.0 | 867.0 | Motif | Bipartite nuclear localization signal |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 148_184 | 18.0 | 867.0 | Repeat | Note=TPR 3 |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 224_257 | 18.0 | 867.0 | Repeat | Note=TPR 4 |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 374_407 | 18.0 | 867.0 | Repeat | Note=TPR 5 |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 409_441 | 18.0 | 867.0 | Repeat | Note=TPR 6 |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 46_79 | 18.0 | 867.0 | Repeat | Note=TPR 1 |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 485_518 | 18.0 | 867.0 | Repeat | Note=TPR 7 |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 672_705 | 18.0 | 867.0 | Repeat | Note=TPR 8 |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 80_113 | 18.0 | 867.0 | Repeat | Note=TPR 2 |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 124_129 | 264.3333333333333 | 365.0 | Region | Lysophosphatidic acid binding | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 124_129 | 264.3333333333333 | 365.0 | Region | Lysophosphatidic acid binding | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 124_129 | 264.3333333333333 | 365.0 | Region | Lysophosphatidic acid binding | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 108_121 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 145_163 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 185_204 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 1_50 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 226_255 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 76_83 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 108_121 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 145_163 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 185_204 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 1_50 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 226_255 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 76_83 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 108_121 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 145_163 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 185_204 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 1_50 | 264.3333333333333 | 365.0 | Topological domain | Note=Extracellular | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 226_255 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 76_83 | 264.3333333333333 | 365.0 | Topological domain | Note=Cytoplasmic | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 122_144 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D3 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 164_184 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D4 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 205_225 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D5 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 256_280 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D6 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 51_75 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D1 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000358883 | 2 | 4 | 84_107 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D2 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 122_144 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D3 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 164_184 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D4 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 205_225 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D5 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 256_280 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D6 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 51_75 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D1 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374430 | 3 | 5 | 84_107 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D2 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 122_144 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D3 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 164_184 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D4 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 205_225 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D5 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 256_280 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D6 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 51_75 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D1 | |
| Tgene | LPAR1 | chr4:140222985 | chr9:113638002 | ENST00000374431 | 3 | 5 | 84_107 | 264.3333333333333 | 365.0 | Transmembrane | Note=Helical%3B Name%3D2 |
Top |
Fusion Protein Structures |
| PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
| Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
| PDB file >>>77_NAA15_140222985_LPAR1_113638002_ranked_0.pdb | NAA15 | 140222985 | 140222985 | ENST00000538760 | LPAR1 | chr9 | 113638002 | - | MTEPGGGGSSGSSRNDAGREPPAQGECALQADLGAFIICWTPGLVLLLLDVCCPQCDVLAYEKFFLLLAEFNSAMNPIIYSYRDKEMSAT | 133 |
Top |
pLDDT score distribution |
| pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
NAA15_pLDDT.png  |
LPAR1_pLDDT.png  |
| pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
 |
Top |
Ramachandran Plot of Fusion Protein Structure |
| Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
| Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| NAA15 | |
| LPAR1 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | NAA15 | chr4:140222985 | chr9:113638002 | ENST00000296543 | + | 1 | 20 | 500_866 | 18.0 | 867.0 | HYPK |
Top |
Related Drugs to NAA15-LPAR1 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to NAA15-LPAR1 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies